Citadel Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-30,376
Closed -$15.3K 11806
2020
Q3
$16K Buy
+30,376
New +$21.8K ﹤0.01% 9902
2020
Q2
Sell
-81,333
Closed -$69K 10816
2020
Q1
$69K Buy
81,333
+33,645
+71% +$48.1K ﹤0.01% 8865
2019
Q4
$78K Buy
47,688
+30,254
+174% +$45.4K ﹤0.01% 8641
2019
Q3
$19K Buy
17,434
+5,026
+41% +$5.81K ﹤0.01% 8954
2019
Q2
$15K Buy
+12,408
New +$15.8K ﹤0.01% 8986
2019
Q1
Sell
-59,813
Closed -$71K 10141
2018
Q4
$71K Buy
59,813
+16,387
+38% +$24.3K ﹤0.01% 8391
2018
Q3
$59K Sell
43,426
-8,956
-17% -$14.2K ﹤0.01% 8772
2018
Q2
$120K Buy
+52,382
New +$101K ﹤0.01% 8164
2018
Q1
Sell
-26,805
Closed -$20K 9011
2017
Q4
$20K Sell
26,805
-13,325
-33% -$11.9K ﹤0.01% 7831
2017
Q3
$47K Sell
40,130
-44,913
-53% -$56.6K ﹤0.01% 7197
2017
Q2
$148K Sell
85,043
-115,670
-58% -$246K ﹤0.01% 6750
2017
Q1
$530K Buy
200,713
+170,036
+554% +$611K ﹤0.01% 4920
2016
Q4
$130K Sell
30,677
-60,446
-66% -$199K ﹤0.01% 6573
2016
Q3
$243K Buy
+91,123
New +$210K ﹤0.01% 6020
2016
Q2
Sell
-11,775
Closed -$27K 7639
2016
Q1
$27K Sell
11,775
-33,769
-74% -$76.4K ﹤0.01% 6400
2015
Q4
$158K Buy
+45,544
New +$218K ﹤0.01% 6140
2015
Q3
Sell
-178,581
Closed -$1.18M 9389
2015
Q2
$1.18M Buy
178,581
+68,221
+62% +$460K ﹤0.01% 3750
2015
Q1
$786K Buy
+110,360
New +$832K ﹤0.01% 4264

Other funds holding GEN

Citadel Advisors's GEN Position: Q4 2020 in Review

Citadel Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 30,376 shares — an estimated $15.3K sold.

Citadel Advisors first reported a position in GEN in Q1 2015 and held it in 18 quarters. The position peaked at $1.18M in Q2 2015. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.

  • Citadel Advisors reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
  • Citadel Advisors sold 30,376 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $15.3K.
  • Citadel Advisors first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 18 quarters.
  • Citadel Advisors's Genesis Healthcare, Inc. position peaked at $1.18M in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.